350
Views
18
CrossRef citations to date
0
Altmetric
Review

Haematological safety of antipsychotic drugs

, &
Pages 395-399 | Published online: 03 Mar 2005

Bibliography

  • ARANA GW: An overview of side effects caused by typical antipsychotics. J. Clin. Psychiatry (2000) 61(S8):S5–S11.
  • EDWARDS JG: Unwanted effects of psychotropic drugs. I. Effects on human physiological systems. In: Seminars in Clinical Psychopharmacology. King DJ (Ed), Gaskell, London. In Press.
  • BALON MD, BERCHOU R: Hematologic side effects of psychotropic drugs. Psychosomatics (1986) 27(2):119–127.
  • •Good overview review article.
  • BALESTRIERI M, VAMPINI C, BELLANTUONO C: Efficacy and safety of novel antipsychotics: a critical review Hum. Psychopharmacol (2000) 15:499–512.
  • GEDDES J, FREEMANTLE N, HARRISON P, BEBBINGTON P: Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br. Med J. (2000) 321:1371–1376.
  • KANE J, HONIGFELD G, SINGER J, MELTZER HY: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry (1988) 45:789–796.
  • MELTZER FLY, BASTANI B, KWON K et al.: A prospective study of clozapine in the treatment of resistant schizophrenic patients. Psychopharmacology (1989) 99:S68–S72.
  • MELTZER HY: Dimensions of outcome with clozapine. Br. J. Psychiatry (1992) 160\(Suppl. 17):46–53.
  • MELTZER FLY, ALPHS L, GREEN AI et al.: Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry (2003) 60:82–91.
  • BARNES TRE, MCPHILLIPS MA: Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. Br. J. Psychiatry (1999) 174(538):534–543.
  • LIEBERMAN JA, JOHNS CA, KANE JA et al.: Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. J. Clin. Psychiatry (1988) 49(7):271–277.
  • •Particularly interesting as the case details are revealed.
  • ATKIN K, KENDALL F, GOULD D, FREEMAN H: Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br. J. Psychiatry (1966) 169:483–488.
  • •Describes UK cases.
  • WAHLBECK K, CHEINE M, ESSALI MA, REZK E: Clozapine vs 'typical' neuroleptic medication for schizophrenia (Cochrane review). In: The Cochrane Library Issue 3. Update Software, Oxford (1998).
  • IDANPAAN-HEIKKILA J, ALHAVA E, OLKINUORA M, PALVA I: Clozapine and agranulocytosis. Lancet (1975) 2:611. Letter.
  • IDANPAAN-HEIKKILA J, ALHAVA E, OLKINUORA M, PALVA IP: Agranulocytosis during treatment with clozapine. Eur. J. Clin. Pharmacol. (1977) 11:193–198.
  • ANDERMAN B, GRIFFITH RW: Clozapine-induced agranulocytosis: a situation report up to August 1977. Eur. J. Clin. PharmacoL (1977) 11:199–201.
  • GRIFFITH RW, SAAMELI K: Clozapine and agranulocytosis. Lancet (1975) 2:657. Letter.
  • DE LA CHAPELLE A, KARI C, NURMINEN M, HERBERG S: Clozapine-induced agranulocytosis. A genetic and epidemiological study. Hum. Genet. (1977) 37:183–194.
  • EDWARDS JG: Withdrawal of psychotropic drugs from the market: I. From thalidomide to zimeldine. In: Human Psychopharmacology (Vol 6). Hindmarch I, Stonier PD (Eds), John Wiley, Chichester, UK (1997):199–214.
  • PISCIOTTA AV, KONINGS SA, CIESEMIER LL et al.: Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis. J. Lab. Clin. Med. (1992) 119:254–266.
  • •Good insight into the mechanisms of the effects of the drug.
  • UETRECHT JP: Metabolism of clozapine by neutrophils. Drug Sal: (1992) 7(S1):S51–S56.
  • ALVIR JMJ, LIEBERMAN JA, SAFFERMAN AZ et al.: Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J. Med (1993) 329(3):162–167.
  • PISCIOTTA AV: Drug-induced agranulocytosis peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. Blood Rev. (1990) 4:226–237.
  • •Good overview review article.
  • VINCENT PC: Drug-induced aplastic anaemia and agranulocytosis: incidence and mechanisms. Drugs (1986) 31:52–63.
  • BARBUI C, CAMPOMORI A, BONATI M: Clozapine and blood dyscrasias different from agranulocytosis. Can. J. Psychiatry (1997) 42(9):981–982.
  • CHATTERTON R Eosinophilia after commencement of clozapine treatment. Aust. NZ J. Psychiatry (1997) 31:874–876.
  • WEIDE R, KOPPLER H, HEYMANNS J et al: Successful treatment of clozapine-induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF). Br. J. Haematol (1992) 80:557–559.
  • MILLER DD: Review and management of clozapine side effects. J. Clin. Psychiatry (2000) 61(58):514–517.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.